Jenny Rooke is the Founder and Managing Director of Genoa Ventures (formerly 5 Prime Ventures).
She serves as Venture Partner at F-Prime Capital Partners. She also serves as Venture Partner at Fidelity Biosciences. She is the Chief Marketing Officer of Zephyrus Biosciences. She brings a combination of strategy, operating, and investing experience to her role as Venture Partner.
She focuses on early stage life science companies on the west coast, specializing in research tools, diagnostics, and synthetic biology. Jenny's investing experience includes roles in the Bill & Melinda Gates Foundation's Global Health Discovery group, and at Fidelity Biosciences, where she served her Kauffman Fellowship. Dr. Rooke held multiple executive positions at U.S. Genomics, a venture-backed biotech start-up advancing single molecule detection technologies for diagnostics, biodefense, and research.
Previously, Dr. Rooke was a management consultant with McKinsey & Co., where she advised leading pharmaceutical and biotech companies on business strategy. Dr. Rooke earned her PhD in genetics from Yale University and her BS in physics from Georgia Tech. She is also a Board Member at Caribou Biosciences.
Fund's investment verticals: research tools, molecular diagnostics, synthetic biology and industrial biology.
MEDIA ABOUT JENNY ROOKE